Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-blind Evaluation of the Positive Predictive Value (PPV) of the MolecuLight i:X™ Imaging Device to Predict the Presence of Pseudomonas Aeruginosa in Chronic Wounds

NCT03290690 is registered in ClinicalTrials.gov with MolecuLight Inc. as lead sponsor.

NCT NCT03290690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03290690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-blind Evaluation of the Positive Predictive Value (PPV) of the MolecuLight i:X™ Imaging Device to Predict the Presence of Pseudomonas Aeruginosa in Chronic Wounds
Lead sponsor
MolecuLight Inc.
Phase
Observational
Overall status
Unknown status
Start date
August 4, 2017
Completion date
July 30, 2020
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic leg ulcer, wound, wound contamination